EPE0843 | Improving multi-month dispensing of antiretroviral therapy at the Mulago most at risk populations initiative clinic, Uganda | E-poster | Implementation science and scale up of treatment |
EPE0842 | Client preference and viral suppression rate among PLHIVs enrolled to community based differentiated ART refill group models in Ethiopia | E-poster | Implementation science and scale up of treatment |
EPE0841 | Lessons learned from pilot implementation of Cryptococcal Meningitis (CM) care package for people with advanced HIV (AHD) in Delhi, India | E-poster | Implementation science and scale up of treatment |
EPE0840 | Theoretical preferences for long-acting injectable ART among mobile men living with HIV in Malawi: a qualitative study | E-poster | Implementation science and scale up of treatment |
EPE0839 | Remind me, track my mood and I will adhere to treatment | E-poster | Implementation science and scale up of treatment |
EPE0838 | Peer-led differentiated support services and HIV treatment outcomes among people living with HIV in China: a propensity-score matched study between 2006-2021 | E-poster | Implementation science and scale up of treatment |
EPE0837 | Mobile units improve HIV testing, ART initiation and treatment continuation among men who have sex with men in Nampula Province, Mozambique | E-poster | Implementation science and scale up of treatment |
EPE0836 | Modelling the potential impact of scaling-up point-of-care HIV viral load testing on the HIV epidemic and drug resistance in Papua New Guinea | E-poster | Implementation science and scale up of treatment |
EPE0835 | Assessment of the awareness of Undetectable=Untransmissible (U=U) messaging among people living with HIV in six regions in Tanzania, 2022 | E-poster | Implementation science and scale up of treatment |
EPE0834 | Continuity of treatment interventions impact on appointment-completion in Mubende region, Uganda, 2022 | E-poster | Implementation science and scale up of treatment |